Comparison of Liver Trauma in Two Retractors Used in Sleeve Gastrectomy
NCT ID: NCT03088683
Last Updated: 2017-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2017-01-31
2017-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COMPARISON OF LIVER RETRACTOR FOR INTRATOPERATIVE LIVER DAMAGE
NCT03795844
Efficacy Evaluation of the Esophagogastric Junction Exposure Obtained by the Flexible Liver Retractor in Gastroplasty
NCT02926885
Laparoscopic Sleeve Gastrectomy: a Cohort Study
NCT03629808
Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure
NCT06338423
Evaluation of Safety and Efficacy of the EndoLift Liver Retractor
NCT02008409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Operative Technique
All patients will be operated by same surgeons. and anesthetist. Peroperatively intravenous paracetamol 10 mg, tramadol 50 mg and fentanyl 150 mcg will be used for analgesia. Laparoscopic sleeve gastrectomy will be performed with 5 trocars, in reverse trendelenburg position by creating pneumoperitoneum with 14 mmHg carbon dioxide insufflation. Trocar replacements are one 10-mm trocar in the midline above umbilicus for the endoscope, one 12-mm trocar to right midclavicular line linage to the 10-mm trocar. One 5-mm trocar to the left midclavicular line linage to the 10-mm trocar, one 5-mm trocar to the front axillary line below the left costal margin. Both liver retractors will be placed from 2 cm below the xiphoid process for liver retractor. In nathanson group; after placing the blade of Nathanson retractor below the left lobe of the liver, it will be fixed to the operating table by the other instruments of retractor. In reveel group; the retractor will be placed below the left lobe of the liver and then it will be fixed to the skin with a towel clamp. 38 F orogastric tube will be used. No use of nasogastric tubes and urinary catheters routinely is planned. Drain replacement is planned for all patients.
Preoperative and postoperative values of the markers will be analysed and compared between two groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nathanson Retractor
Nathanson retractor will be used
Nathanson Retractor
Liver will be retracted with Nathanson retractor
Reveel Retractor
Reveel retractor will be used
Reveel Retractor
Liver will be retracted with Reveel retractor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nathanson Retractor
Liver will be retracted with Nathanson retractor
Reveel Retractor
Liver will be retracted with Reveel retractor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Umraniye Education and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdullah Sisik
General Surgery Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdullah Sisik
Role: PRINCIPAL_INVESTIGATOR
Umraniye Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nazif Bagriacik Kadioy Hospital
Istanbul, Kadikoy, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMP-LIV-RET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.